T-group (topology)
5084.5.3 Ligand-gated protein channel
Ligands and drugs
312
Member domains
201
with ligand contacts (≤ 4 Å)
64.4% of members
182
with DrugDomain annotations
58.3% of members
113
with a DrugBank compound
36.2% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5084.5.3 belongs to X-group 5084 Outer membrane meander beta-barrels, which binds 9.4 ligand superclasses per 20 proteins, broader than 87% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB08249 | N8E | 3,6,9,12,15-PENTAOXATRICOSAN-1-OL | 18 |
| DB02767 | FTT | (R)-3-hydroxytetradecanoic acid | 9 |
| DB00115 | CNC | Cyanocobalamin | 5 |
| DB03017 | DAO | Lauric acid | 5 |
| DB18267 | HEM | Ferroheme | 5 |
| DB03574 | FCI | Ferricrocin-iron | 4 |
| DB08217 | MTN | S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate | 4 |
| DB08231 | MYR | Myristic acid | 4 |
| DB00142 | GLU | Glutamic acid | 3 |
| DB02415 | OES | N-Octyl-2-Hydroxyethyl Sulfoxide | 3 |
| DB02907 | EAP | 2-Amino-Vinyl-Phosphate | 3 |
| DB04039 | LIM | 3-Oxo-Pentadecanoic Acid | 3 |
| DB01814 | LIL | 2-Tridecanoyloxy-Pentadecanoic Acid | 2 |
| DB01747 | HWS | Coprogen | 1 |
| DB01762 | AAE | Acetoacetic acid | 1 |
| DB02451 | BNG | B-nonylglucoside | 1 |
| DB02626 | PFC | Phenylferricrocin-iron | 1 |
| DB02724 | ALB | Delta-2-Albomycin A1 | 1 |
| DB03111 | GP1 | Glucosamine 1-Phosphate | 1 |
| DB03317 | HEC | Ferroheme C | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 27 |
| FEmetal | FE (III) ION | 18 |
| N8E | 3,6,9,12,15-PENTAOXATRICOSAN-1-OL | 18 |
| CAmetal | CALCIUM ION | 13 |
| NAmetal | SODIUM ION | 13 |
| CUmetal | COPPER (II) ION | 12 |
| AGmetal | SILVER ION | 10 |
| PVE | (1S)-1-CARBOXY-5-[(3-CARBOXYPROPANOYL)AMINO]-8,9-DIHYDROXY-1,2,3,4-TETRAHYDROPYRIMIDO[1,2-A]QUINOLIN-11-IUM | 10 |
| FTT | 3-HYDROXY-TETRADECANOIC ACID | 9 |
| DPO | DIPHOSPHATE | 8 |
| Kmetal | POTASSIUM ION | 8 |
| HEM | PROTOPORPHYRIN IX CONTAINING FE | 6 |
| KR0 | 3-decanoyloxypropyl decanoate | 6 |
| 5PL | (1R,4S,6R)-6-({[2-(ACETYLAMINO)-2-DEOXY-ALPHA-D-GLUCOPYRANOSYL]OXY}METHYL)-4-HYDROXY-1-{[(15-METHYLHEXADECANOYL)OXY]METHYL}-4-OXIDO-7-OXO-3,5-DIOXA-8-AZA-4-PHOSPHAHEPTACOS-1-YL 15-METHYLHEXADECANOATE | 5 |
| CNC | CYANOCOBALAMIN | 5 |
| DAO | LAURIC ACID | 5 |
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 4 |
| FCI | FERRICROCIN-IRON | 4 |
| MTN | S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate | 4 |
| MYR | MYRISTIC ACID | 4 |